Antiplatelets Cut Preterm Birth in Those at Risk for Preeclampsia

Share this content:
Antiplatelets Cut Preterm Birth in Those at Risk for Preeclampsia
Antiplatelets Cut Preterm Birth in Those at Risk for Preeclampsia

TUESDAY, Jan. 17, 2017 (HealthDay News) -- Among women at risk for preeclampsia, antiplatelet agents reduce the risk of spontaneous preterm birth at less than 37 and less than 34 weeks of gestation, according to a meta-analysis published in the February issue of Obstetrics & Gynecology.

Elvira O.G. van Vliet, M.D., Ph.D., from the University of Sydney, and colleagues conducted a meta-analysis using data from 17 trials (with 28,797 women) to examine whether use of antiplatelet agents reduces the risk of spontaneous preterm birth. Data were included from studies that randomized women to low-dose aspirin-dipyridamole or placebo-no treatment as a primary prevention strategy for preeclampsia.

The researchers found that the risks of spontaneous preterm birth at less than 37 weeks and less than 34 weeks of gestation were reduced (relative risks, 0.93 [95 percent confidence interval, 0.86 to 0.996] and 0.86 [95 percent confidence interval, 0.76 to 0.99], respectively) for women assigned to antiplatelet treatment versus placebo or no treatment. The relative risk of having a spontaneous preterm birth at less than 37 weeks of gestation was 0.83 (95 percent confidence interval, 0.73 to 0.95) and 0.98 (95 percent confidence interval, 0.89 to 1.09) for women who had a previous pregnancy and for women in their first pregnancy, respectively. Across all other prespecified subgroups the treatment effect was stable.

"Antiplatelet agents reduce spontaneous preterm birth in pregnant women at risk for preeclampsia," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »